Pricing Log in Create free account

Cardiol Therapeutics Inc. (CRDL) vs Journey Medical Corporation (DERM)

Cardiol Therapeutics Inc. and Journey Medical Corporation are both Drug Manufacturers Specialty & Generic companies. Cardiol Therapeutics Inc. and Journey Medical Corporation are of similar size ($121.4M and $111.8M). Cardiol Therapeutics Inc. has the higher net margin (0.00% vs −8.95%) and the higher return on invested capital (0.00% vs −5.89%). Across the 14 metrics below, Cardiol Therapeutics Inc. leads on 7 and Journey Medical Corporation on 7.

Valuation

Metric CRDL DERM Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S n/m 1.73 2.08
P/B 6.16 3.68 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m 67.73 12.22
EV/Sales n/m 1.73 2.87
Earnings yield (26.88%) (5.12%) (15.94%)
Free cash flow yield (16.13%) (19.02%) 0.00%

Profitability

Metric CRDL DERM Drug Manufacturers Specialty & Generic median
Gross margin 0.00% 65.45% 53.51%
Operating margin 0.00% (4.41%) 0.00%
Net margin 0.00% (8.95%) (2.45%)
Free cash flow margin 0.00% (10.99%) 0.00%
Return on equity (171.13%) (23.77%) (0.80%)
Return on assets (124.40%) (6.80%) (1.67%)
Return on invested capital 0.00% (5.89%) 0.00%

Growth

Metric CRDL DERM Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 20.89% 5.22%
EPS growth (last fiscal year) 24.32% 34.72% 42.91%
Revenue growth, 5-year CAGR — 6.79% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRDL DERM Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.79 0.04
Current ratio 5.55 1.59 2.41
Net debt to EBITDA 0.62 (0.35) 1.01

Dividend

Metric CRDL DERM Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric CRDL DERM Drug Manufacturers Specialty & Generic median
Market cap 111.79m 121.36m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack